These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1328073)

  • 21. Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2.
    Xu F; Leadon SA; Yu Y; Boyer CM; O'Briant K; Ward K; McWatters A; Zhao X; Bae DS; DeSombre K; Zalutsky MR; Bast RC
    Clin Cancer Res; 2000 Aug; 6(8):3334-41. PubMed ID: 10955821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunotoxins recognising a new epitope on the neural cell adhesion molecule have potent cytotoxic effects against small cell lung cancer.
    Zangemeister-Wittke U; Collinson AR; Frösch B; Waibel R; Schenker T; Stahel RA
    Br J Cancer; 1994 Jan; 69(1):32-9. PubMed ID: 7506925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potent and specific killing of human malignant brain tumor cells by an anti-transferrin receptor antibody-ricin immunotoxin.
    Zovickian J; Johnson VG; Youle RJ
    J Neurosurg; 1987 Jun; 66(6):850-61. PubMed ID: 3033171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunotoxin therapy of small-cell lung cancer: a phase I study of N901-blocked ricin.
    Lynch TJ; Lambert JM; Coral F; Shefner J; Wen P; Blattler WA; Collinson AR; Ariniello PD; Braman G; Cook S; Esseltine D; Elias A; Skarin A; Ritz J
    J Clin Oncol; 1997 Feb; 15(2):723-34. PubMed ID: 9053498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of anti-epidermal growth factor (EGF) receptor antibodies and an anti-EGF receptor recombinant-ricin A chain immunoconjugate on growth of human cells.
    Taetle R; Honeysett JM; Houston LL
    J Natl Cancer Inst; 1988 Sep; 80(13):1053-9. PubMed ID: 3261802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structural features of the antibody-A chain linkage that influence the activity and stability of ricin A chain immunotoxins.
    Cumber AJ; Westwood JH; Henry RV; Parnell GD; Coles BF; Wawrzynczak EJ
    Bioconjug Chem; 1992; 3(5):397-401. PubMed ID: 1329989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selective killing of tumor cells in vitro by an immunotoxin composed of ricin and monoclonal antibody against Ia antigen.
    Wu M; Tang SL; Zang RJ; Yu H
    Int J Immunopharmacol; 1990; 12(2):235-9. PubMed ID: 2329015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-tumor effects and lack of side effects in mice of an immunotoxin directed against human and mouse prostate-specific membrane antigen.
    Huang X; Bennett M; Thorpe PE
    Prostate; 2004 Sep; 61(1):1-11. PubMed ID: 15287089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunotoxin therapy of small-cell lung cancer. N901-blocked ricin for relapsed small-cell lung cancer.
    Lynch TJ
    Chest; 1993 Apr; 103(4 Suppl):436S-439S. PubMed ID: 8384975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of chemical deglycosylation of ricin A chain on the in vivo fate and cytotoxic activity of an immunotoxin composed of ricin A chain and anti-Thy 1.1 antibody.
    Blakey DC; Watson GJ; Knowles PP; Thorpe PE
    Cancer Res; 1987 Feb; 47(4):947-52. PubMed ID: 3492271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antidisialoganglioside ricin A-chain immunotoxins show potent antitumor effects in vitro and in a disseminated human neuroblastoma severe combined immunodeficiency mouse model.
    Gottstein C; Schön G; Tawadros S; Kube D; Wargalla-Plate UC; Hansmann ML; Wacker HH; Berthold F; Diehl V; Engert A
    Cancer Res; 1994 Dec; 54(23):6186-93. PubMed ID: 7954465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-CD6-blocked ricin: an anti-pan T-cell immunotoxin.
    Collinson AR; Lambert JM; Liu Y; O'Dea C; Shah SA; Rasmussen RA; Goldmacher VS
    Int J Immunopharmacol; 1994 Jan; 16(1):37-49. PubMed ID: 8150554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytotoxicity against human tumor cells mediated by the conjugate of anti-epidermal growth factor receptor monoclonal antibody to recombinant ricin A chain.
    Masui H; Kamrath H; Apell G; Houston LL; Mendelsohn J
    Cancer Res; 1989 Jul; 49(13):3482-8. PubMed ID: 2786451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bispecific anti-CD22/anti-CD3-ricin A chain immunotoxin is cytotoxic to Daudi lymphoma cells but not T cells in vitro and shows both A-chain-mediated and LAK-T-mediated killing.
    Shen GL; Li JL; Vitetta ES
    J Immunol; 1994 Mar; 152(5):2368-76. PubMed ID: 8133047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperthermia potentiates the activity of immunotoxin conjugates against common acute lymphoblastic leukaemia cells in vitro.
    Herrmann RP; Pelham JM; Raphael CL; Meyer BF; Davis RE
    Ann N Y Acad Sci; 1987; 511():428-35. PubMed ID: 2964219
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro cytotoxicity of recombinant ricin A chain-antitransferrin receptor immunotoxin against human adenocarcinomas of the colon and pancreas.
    Griffin TW; Pagnini PG; McGrath JJ; McCann JC; Houston LL
    J Biol Response Mod; 1988 Dec; 7(6):559-67. PubMed ID: 3265147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunotoxins to human small-cell lung cancer.
    Wawrzynczak EJ; Derbyshire EJ
    Cell Biophys; 1992; 21(1-3):13-23. PubMed ID: 1285325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel synthesis and in vitro characterization of disulfide-linked ricin-monoclonal antibody conjugates devoid of galactose binding activity.
    Pietersz GA; Kanellos J; McKenzie IF
    Cancer Res; 1988 Aug; 48(16):4469-76. PubMed ID: 3260814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monensin in lipid emulsion for the potentiation of ricin A chain immunotoxins.
    Griffin T; Raso V
    Cancer Res; 1991 Aug; 51(16):4316-22. PubMed ID: 1868454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative biochemical, cytotoxic and pharmacokinetic properties of immunotoxins made with native ricin A chain, ricin A1 chain and recombinant ricin A chain.
    Wawrzynczak EJ; Cumber AJ; Henry RV; Parnell GD
    Int J Cancer; 1991 Jan; 47(1):130-5. PubMed ID: 1985869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.